Investigation of interleukines-4, 6 and malondialdehyde levels in serum of Iraqi patients with chronic kidney diseases.

BackgroundImmune dysfunction develops early in the course of renal failure in patients with chronic kidney disease and occurs independently of the underlying disease. Cytokines play an essential role in the control and regulation of the immune and inflammatory systems.ObjectiveThe current study aims to estimate Interleukin 4, Interleukin 6, and Malondialdehyde in the blood of Iraqi patients with chronic kidney disease.MethodsIn this study, 50 Iraqi chronic kidney disease patients (males 17 and females33) and 50 apparently healthy as the control group (male27 and females23) aged (20-65)years who attended lmamain Al-Kadhemain Medical Teaching Hospital and Al-Numan Hospital in Baghdad, Iraq. Interleukin 4, Interleukin 6, and malondialdehyde were measured using an enzyme-linked immunosorbent assay technique.ResultsThe serum level of IL-4 and IL-6 showed highly significant differences between chronic kidney disease patients and healthy control groups m as the mean value of both interleukin levels in patient groups was (25.524 ± 16.295, 12.844 ± 4.863) respectively, and mean of the control group (13.562 ± 7.488, 5.533 ± 2.970) respectively. The mean of malondialdehyde was (25.160 ± 17.152 and18.470 ± 6.545) in chronic kidney disease patients and control groups, respectively. There was a highly significant positive correlation between Interleukin6 and malondialdehyde (r = 0.862, P = 0.0001, r = 0.598, P = 0.0001), respectively. In addition, there was a highly significant positive correlation between Interleukin4 and malondialdehyde (r = 0.862, P = 0.0001, r = 0.662, P = 0.0001) respectively. There was a highly significant positive correlation between Interleukin 4 and Interleukin 6 (r = 0.598, P = 0.0001) and (r = 0.662, P = 0.0001) respectively.ConclusionsThe increased levels of Interleukin 4, Interleukin 6, and malondialdehyde are an indication of the progression in Iraqi patients with chronic kidney disease.